Literature DB >> 19176492

Identification of cancer stem cells in dog glioblastoma.

G Stoica1, G Lungu, H Martini-Stoica, S Waghela, J Levine, R Smith.   

Abstract

There is increasing evidence in some malignancies that the tumor clone is heterogeneous in regard to proliferation and differentiation. The cancer stem cell hypothesis implies that not all the cells in the tumor have the same capacity to proliferate and maintain the growth of the tumor. Only a relatively small fraction of cells in the tumor, termed cancer stem cells (CSCs), possess the ability to proliferate and self-renew extensively. In the past decade, several groups have reported the existence of a CSC population in different human brain tumors from both children and adults. We report here the identification of a CSC population from a Boxer dog with glioblastoma multiforme (GBM) that possesses a great capacity for proliferation, self-renewal, and differentiation. This cloned cell line is aneuploid, forms neurospheres in culture, possesses CSC markers, and reproduces the original dog GBM when inoculated into the nude mouse brain.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19176492     DOI: 10.1354/vp.08-VP-0218-S-FL

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  21 in total

1.  Radiobiological characteristics of cancer stem cells from esophageal cancer cell lines.

Authors:  Jian-Lin Wang; Jing-Ping Yu; Zhi-Qiang Sun; Su-Ping Sun
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

2.  Canine spontaneous glioma: a translational model system for convection-enhanced delivery.

Authors:  Peter J Dickinson; Richard A LeCouteur; Robert J Higgins; John R Bringas; Richard F Larson; Yoji Yamashita; Michal T Krauze; John Forsayeth; Charles O Noble; Daryl C Drummond; Dmitri B Kirpotin; John W Park; Mitchel S Berger; Krystof S Bankiewicz
Journal:  Neuro Oncol       Date:  2010-05-20       Impact factor: 12.300

3.  Comparison of cancer stem cell antigen expression by tumor cell lines and by tumor biopsies from dogs with melanoma and osteosarcoma.

Authors:  Amanda M Guth; Mike Deogracias; Steven W Dow
Journal:  Vet Immunol Immunopathol       Date:  2014-07-24       Impact factor: 2.046

Review 4.  The art of gene therapy for glioma: a review of the challenging road to the bedside.

Authors:  Alex Tobias; Atique Ahmed; Kyung-Sub Moon; Maciej S Lesniak
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-09-19       Impact factor: 10.154

5.  Identification of rhodamine 123-positive stem cell subpopulations in canine hepatocellular carcinoma cells.

Authors:  Harumichi Itoh; Shimpei Nishikawa; Tomoya Haraguchi; Yu Arikawa; Masato Hiyama; Toshie Iseri; Yoshiki Itoh; Munekazu Nakaichi; Yasuho Taura; Kenji Tani; Kazuhito Itamoto
Journal:  Biomed Rep       Date:  2017-06-07

6.  Insights into leukemia-initiating cell frequency and self-renewal from a novel canine model of leukemia.

Authors:  Suzan Imren; Xiao-Bing Zhang; R Keith Humphries; Hans-Peter Kiem
Journal:  Exp Hematol       Date:  2010-10-08       Impact factor: 3.084

Review 7.  Survivin as a novel target protein for reducing the proliferation of cancer cells.

Authors:  Dongyu Li; Chenghao Hu; Huibin Li
Journal:  Biomed Rep       Date:  2018-03-13

Review 8.  Vertebrate animal models of glioma: understanding the mechanisms and developing new therapies.

Authors:  Leon Chen; Yuqing Zhang; Jingxuan Yang; John P Hagan; Min Li
Journal:  Biochim Biophys Acta       Date:  2013-04-22

Review 9.  Gene therapy for brain cancer: combination therapies provide enhanced efficacy and safety.

Authors:  Marianela Candolfi; Kurt M Kroeger; A K M G Muhammad; Kader Yagiz; Catherine Farrokhi; Robert N Pechnick; Pedro R Lowenstein; Maria G Castro
Journal:  Curr Gene Ther       Date:  2009-10       Impact factor: 4.391

10.  Modulation of fatty acid metabolism and immune suppression are features of in vitro tumour sphere formation in ontogenetically distinct dog cancers.

Authors:  J-H Kim; A M Frantz; A L Sarver; B H Gorden Klukas; M Lewellen; T D O'Brien; E B Dickerson; J F Modiano
Journal:  Vet Comp Oncol       Date:  2017-11-20       Impact factor: 2.613

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.